Global Scientific Services
Research & Development (R&D)
Mannatech understands that the key to superior product development is a vibrant R&D department. Co-CEO Dr. Robert Sinnott, Mannatech’s Global Chief Science Officer, leads Mannatech’s Global Scientific Services team of physicians, scientists, and experts in product development, product safety, regulatory affairs, and quality assurance.
Mannatech’s Product Development Team actively explores new technologies to develop innovative products that meet the needs of today’s sophisticated consumer.
Mannatech’s Research Group is devoted to pre-clinical and clinical testing of products and product ingredients. To more effectively meet our research goals, we collaborate with researchers around the world. Many of the publications that report the results of these studies are posted in Publications.
Mannatech’s Product Safety Monitoring program—which has been functioning for over 10 years, long before it was required by the FDA—tracks and maintains an extensive database that continues to help ensure the safety of our products.
|
Seated row (left to right): Mary Wood, Morgan Barg, Bhavna Patel, Kay Chichilla, Christy Duncan, Barbara Kinsey, Jane Ramberg Standing row (left to right): Rob Moore, Jennifer Aponte, Angela Bowen, Dana Fuller, Peter Suphasawud, Monica Hunter, Tait Switzer, Josh Edwards, Rolando Maddela, Gabriela Luta, Amy Bart, Robert A. Sinnott,
|
Quality Assurance (QA)
Mannatech’s Quality Assurance program complies with the U.S. Food and Drug Administration’s (FDA) Good Manufacturing Practices (GMPs) for Dietary Supplements (21CFR111), which impact all aspects of product development, manufacture, evaluation, storage and distribution. We use scientifically sound and appropriate specifications, sampling plans and testing procedures to ensure that materials, components and finished products conform to appropriate quality standards.
Regulatory Affairs (RA)
Mannatech’s Regulatory Affairs team of professionals ensures that all product formulations are produced in compliance with each country’s specific regulatory agencies (e.g., FDA, Health Canada, Australian Therapeutic Goods Administration, Japan Ministry of Health Labor and Welfare, Korea Food and Drug Administration, Taiwan Department of Health and the European Union and Member State Authorities).
|
Seated row (left to right): Sharon McNair, Nneka Onwumere, Chandra Colandrea, June Herling Standing row (left to right): Gary Carter, Lorena Macias, Marcella Seymour, Mary Carter, Not pictured: Dom Komorovskaya
|
.jpg)
Our Scientists
|
||||||||||||||||||||||||||||
.jpg)
